Netoglitazone

The major eicosanoid product of mast cells, certain macrophages, and the predominant PG in the cerebral spinal fluid. PGD2 inhibits platelet aggregation, induces sleep, causes flushing, vasodilation and nasal congestion, and immune modulation,

The major eicosanoid product of mast cells, certain macrophages, and the predominant PG in the cerebral spinal fluid. PGD2 inhibits platelet aggregation, induces sleep, causes flushing, vasodilation and nasal congestion, and immune modulation,

Prostaglandin D|2|-d|9|contains nine deuterium atoms at the 17, 17', 18, 18', 19, 19', 20, 20, and 20 positions and is intended for use as an internal standard for the quantification of PGD|2|by GC- or LC-mass spectrometry. PGD|2|is the major

Prostaglandin D|2|-d|9|contains nine deuterium atoms at the 17, 17', 18, 18', 19, 19', 20, 20, and 20 positions and is intended for use as an internal standard for the quantification of PGD|2|by GC- or LC-mass spectrometry. PGD|2|is the major

A cell-permeable, 3-acryl-acrylamide derivative that acts as a highly potent, selective, and competitive antagonist of prostaglandin E2 receptor (EP2, K b = 17.8 nM).

A weak FP receptor antagonist.

A weak FP receptor antagonist.

A weak FP receptor antagonist.

PROTAC CDK12/13 Degrader-1 (7f) TFA is a highly selective cell cycle protein-dependent kinase CDK12/CDK13 dual degrader with the DC 50 values of 2.2 nM and 2.1 nM, respectively. PROTAC CDK12/13 Degrader-1 TFA has anti-proliferative activity and can

PROTAC CDK12/13 Degrader-1 (7f) TFA is a highly selective cell cycle protein-dependent kinase CDK12/CDK13 dual degrader with the DC 50 values of 2.2 nM and 2.1 nM, respectively. PROTAC CDK12/13 Degrader-1 TFA has anti-proliferative activity and can

Harmonized Tariff Code:  3822.00

Harmonized Tariff Code:  3822.00